SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001854270-24-000069
Filing Date
2024-05-29
Accepted
2024-05-29 16:07:46
Documents
4
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY a20240529def14adocsentibio.htm DEF 14A 593986
2 image_1a.jpg GRAPHIC 19056
3 proxycard_p1a.jpg GRAPHIC 187682
4 proxycard_p2a.jpg GRAPHIC 137654
  Complete submission text file 0001854270-24-000069.txt   1069149
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40440 | Film No.: 24998392
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)